Myint Han 4
4 · NextCure, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Myint Han
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-01-31+103,600→ 103,600 totalExercise: $5.57Exp: 2032-01-30→ Common Stock (103,600 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023.